These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 2218781)
1. Indoramin in the treatment of pregnancy hypertension. A placebo-controlled trial comparing the efficacy of indoramin with alpha-methyldopa. Anthony J; Rees AE; Davey DA S Afr Med J; 1990 Oct; 78(8):458-61. PubMed ID: 2218781 [TBL] [Abstract][Full Text] [Related]
2. Comparison of indoramin and methyldopa in hypertension. Rosendorff C S Afr Med J; 1976 May; 50(20):764-8. PubMed ID: 779054 [TBL] [Abstract][Full Text] [Related]
3. Double blind evaluation of indoramin and methyldopa in thiazide treated hypertensive patients. Yajnik VH; Patel SC Indian Heart J; 1978; 30(1):51-6. PubMed ID: 359454 [No Abstract] [Full Text] [Related]
4. [Effect of alpha-methyldopa (Dopegyt) on blood pressure in hypertensive pregnant patients]. During R; Schwarzlos G Zentralbl Gynakol; 1985; 107(6):357-62. PubMed ID: 4002921 [TBL] [Abstract][Full Text] [Related]
5. Clonidine hydrochloride--a safe and effective antihypertensive agent in pregnancy. Horvath JS; Phippard A; Korda A; Henderson-Smart DJ; Child A; Tiller DJ Obstet Gynecol; 1985 Nov; 66(5):634-8. PubMed ID: 3903581 [TBL] [Abstract][Full Text] [Related]
6. Indoramin in the treatment of hypertension. A mini-review and update. Archibald JL; Turner P S Afr Med J; 1983 Feb; 63(9):307-9. PubMed ID: 6338605 [TBL] [Abstract][Full Text] [Related]
7. The use of antihypertensive drugs in hypertension in pregnancy. Redman CW Clin Obstet Gynaecol; 1977 Dec; 4(3):685-705. PubMed ID: 23234 [No Abstract] [Full Text] [Related]
9. A comparative evaluation of metoprolol and methyldopa in the management of pregnancy induced hypertension. Oumachigui A; Verghese M; Balachander J Indian Heart J; 1992; 44(1):39-41. PubMed ID: 1398694 [TBL] [Abstract][Full Text] [Related]
10. Indoramin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and related vascular, cardiovascular and airway diseases. Holmes B; Sorkin EM Drugs; 1986 Jun; 31(6):467-99. PubMed ID: 3525084 [TBL] [Abstract][Full Text] [Related]
11. Indoramin in the treatment of hypertension: a placebo controlled trial. Ramirez J Curr Med Res Opin; 1976; 4(3):177-84. PubMed ID: 780059 [TBL] [Abstract][Full Text] [Related]
12. [Open study on the effect and side effects of indoramin, used at the 2d and 3d therapeutic step in essential hypertension]. Hitzenberger G; Korn A Wien Med Wochenschr; 1985 Sep; 135(17):425-30. PubMed ID: 4060742 [TBL] [Abstract][Full Text] [Related]
13. Antihypertensive therapy with indoramin: risk-benefit profile in clinical practice. Stannard M; Cohen M; Marrott PK; Pascucci VL J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S48-52. PubMed ID: 2423797 [TBL] [Abstract][Full Text] [Related]
14. Trends in using beta-blockers and methyldopa for hypertensive disorders during pregnancy in a Canadian population. Xie RH; Guo Y; Krewski D; Mattison D; Nerenberg K; Walker MC; Wen SW Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):281-5. PubMed ID: 24139131 [TBL] [Abstract][Full Text] [Related]
15. A comparison of nifedipine with methyldopa in pregnancy induced hypertension. Jayawardana J; Lekamge N Ceylon Med J; 1994 Jun; 39(2):87-90. PubMed ID: 7923458 [TBL] [Abstract][Full Text] [Related]
20. Utilization of hydralazine or alpha-methyldopa for the management of early puerperal hypertension. Griffis KR; Martin JN; Palmer SM; Martin RW; Morrison JC Am J Perinatol; 1989 Oct; 6(4):437-41. PubMed ID: 2789542 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]